[Treatment of rheumatoid arthritis using D-penicillamine].
D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001673:Biodegradation, Environmental; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D007700:Kinetics; D008134:Long-Term Care; D009461:Neurologic Manifestations; D010396:Penicillamine / Q000008:administration & dosage / Q000009:adverse effects / Q000096:biosynthesis / Q000266:history / Q000494:pharmacology / Q000627:therapeutic use*; D011115:Polyneuropathies / Q000139:chemically induced; D012877:Skin Manifestations
D010396:Penicillamine
Die Behandlung mit D-Penicillamin bei rheumatoider Arthritis.